Overview

Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia and Africa. This trial aims for a comparison of blood glucose control of biphasic human insulin 100 IU/mL and EX1000.
Phase:
Phase 2
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc